BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 32187665)

  • 21. PTEN mutation predicts unfavorable fertility preserving treatment outcome in the young patients with endometrioid endometrial cancer and atypical hyperplasia.
    Xue Y; Dong Y; Lou Y; Lv Q; Shan W; Wang C; Chen X
    J Gynecol Oncol; 2023 Jul; 34(4):e53. PubMed ID: 36929579
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High frequency of POLE mutations in synchronous endometrial and ovarian carcinoma.
    Ishikawa M; Nakayama K; Nakamura K; Ono R; Yamashita H; Ishibashi T; Minamoto T; Iida K; Razia S; Ishikawa N; Kyo S
    Hum Pathol; 2019 Mar; 85():92-100. PubMed ID: 30448219
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Loss of ARID1A expression in endometrial samplings is associated with the risk of endometrial carcinoma.
    Yen TT; Miyamoto T; Asaka S; Chui MH; Wang Y; Lin SF; Stone RL; Fader AN; Asaka R; Kashima H; Shiozawa T; Wang TL; Shih IM; Tanner EJ
    Gynecol Oncol; 2018 Sep; 150(3):426-431. PubMed ID: 30126589
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeted sequencing with a customized panel to assess histological typing in endometrial carcinoma.
    Cuevas D; Valls J; Gatius S; Roman-Canal B; Estaran E; Dorca E; Santacana M; Vaquero M; Eritja N; Velasco A; Matias-Guiu X
    Virchows Arch; 2019 May; 474(5):585-598. PubMed ID: 30710169
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ARID1A loss is prevalent in endometrial hyperplasia with atypia and low-grade endometrioid carcinomas.
    Werner HM; Berg A; Wik E; Birkeland E; Krakstad C; Kusonmano K; Petersen K; Kalland KH; Oyan AM; Akslen LA; Trovik J; Salvesen HB
    Mod Pathol; 2013 Mar; 26(3):428-34. PubMed ID: 23080032
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical Targeted Next-Generation Sequencing Shows Increased Mutational Load in Endometrioid-type Endometrial Adenocarcinoma With Deficient DNA Mismatch Repair.
    Lee PJ; McNulty S; Duncavage EJ; Heusel JW; Hagemann IS
    Int J Gynecol Pathol; 2018 Nov; 37(6):581-589. PubMed ID: 29084048
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Histotype-genotype correlation in 36 high-grade endometrial carcinomas.
    Hoang LN; McConechy MK; Köbel M; Han G; Rouzbahman M; Davidson B; Irving J; Ali RH; Leung S; McAlpine JN; Oliva E; Nucci MR; Soslow RA; Huntsman DG; Gilks CB; Lee CH
    Am J Surg Pathol; 2013 Sep; 37(9):1421-32. PubMed ID: 24076778
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genome-wide mutation analysis in precancerous lesions of endometrial carcinoma.
    Li L; Yue P; Song Q; Yen TT; Asaka S; Wang TL; Beavis AL; Fader AN; Jiao Y; Yuan G; Shih IM; Song Y
    J Pathol; 2021 Jan; 253(1):119-128. PubMed ID: 33016334
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PIK3CA missense mutation is associated with unfavorable outcome in grade 3 endometrioid carcinoma but not in serous endometrial carcinoma.
    McIntyre JB; Nelson GS; Ghatage P; Morris D; Duggan MA; Lee CH; Doll CM; Köbel M
    Gynecol Oncol; 2014 Jan; 132(1):188-93. PubMed ID: 24262879
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular analysis of endometrial hyperplasia in HNPCC-suspicious patients may predict progression to endometrial carcinoma.
    Sutter C; Dallenbach-Hellweg G; Schmidt D; Baehring J; Bielau S; von Knebel Doeberitz M; Gebert J
    Int J Gynecol Pathol; 2004 Jan; 23(1):18-25. PubMed ID: 14668545
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiclonality and Marked Branched Evolution of Low-Grade Endometrioid Endometrial Carcinoma.
    Lazo de la Vega L; Samaha MC; Hu K; Bick NR; Siddiqui J; Hovelson DH; Liu CJ; Carter CS; Cho KR; Sciallis AP; Tomlins SA
    Mol Cancer Res; 2019 Mar; 17(3):731-740. PubMed ID: 30610106
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Morphological diagnosis of endometrial intraepithelial neoplasia and expression of PTEN].
    Zhou WX; Liang ZY; Gao J; Liu TH
    Zhonghua Bing Li Xue Za Zhi; 2009 Jun; 38(6):393-6. PubMed ID: 19781346
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular evidence for a clonal relationship between synchronous uterine endometrioid carcinoma and ovarian clear cell carcinoma: a new example of "precursor escape"?
    Weng CH; Wu RC; Chen SJ; Chen HC; Tan KT; Lee YS; Huang SS; Yang LY; Wang CJ; Chou HH; Chao AS; Chao A; Lai CH
    J Mol Med (Berl); 2021 Jul; 99(7):959-966. PubMed ID: 33768299
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Endometrial carcinoma and precursor lesions].
    Djordjević B; Stanojević Z
    Srp Arh Celok Lek; 2007; 135(3-4):230-4. PubMed ID: 17642468
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discordant Mutations in Paired Primary and Metastatic Endometrial Adenocarcinomas Identified by Semiconductor-Based Sequencing for Rapid Cancer Genotyping.
    Bergstrom CP; Geest K; O'Gara R; Corless CL; Morgan TK
    Reprod Sci; 2016 Nov; 23(11):1575-1579. PubMed ID: 27170661
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-throughput interrogation of PIK3CA, PTEN, KRAS, FBXW7 and TP53 mutations in primary endometrial carcinoma.
    Garcia-Dios DA; Lambrechts D; Coenegrachts L; Vandenput I; Capoen A; Webb PM; Ferguson K; ; Akslen LA; Claes B; Vergote I; Moerman P; Van Robays J; Marcickiewicz J; Salvesen HB; Spurdle AB; Amant F
    Gynecol Oncol; 2013 Feb; 128(2):327-34. PubMed ID: 23219661
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression and significance of beta-catenin, Glut-1 and PTEN in proliferative endometrium, endometrial intraepithelial neoplasia and endometrioid adenocarcinoma.
    Xiong Y; Xiong YY; Zhou YF
    Eur J Gynaecol Oncol; 2010; 31(2):160-4. PubMed ID: 20527231
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Significance of phosphoinositide 3 kinase/AKT pathway alterations in endometrial carcinoma].
    Yang X; Dong Y; Zhang XM; Liang Y; Zhang Y; Meng YT; Wang Y; Wang W; Nong L; Li T; Liao QP
    Zhonghua Bing Li Xue Za Zhi; 2011 Dec; 40(12):799-804. PubMed ID: 22336203
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PTEN mutations as predictive marker for the high-grade endometrial cancer development in slovak women.
    Gbelcová H; Gergely L; Šišovský V; Straka Ľ; Böhmer D; Pastoráková A; Sušienková K; Repiská V; Korbeľ M; Danihel Ľ; Priščáková P
    Physiol Res; 2022 Dec; 71(Suppl 1):S125-S135. PubMed ID: 36592448
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutation analysis by whole exome sequencing of endometrial hyperplasia and carcinoma in one patient: Abnormalities of polymerase epsilon and the phosphatidylinositol-3 kinase pathway.
    Miyamoto T; Ando H; Asaka R; Yamada Y; Shiozawa T
    J Obstet Gynaecol Res; 2018 Jan; 44(1):179-183. PubMed ID: 28984400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.